• EU begins real-time review of Sanofi-GSK COVID-19 vaccine expresspharma
    July 22, 2021
    The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early-stage clinical trials in adults, the European Medicines Agency (EMA) said.
PharmaSources Customer Service